• Market Intelligence Toolkit
  • Barriers To Entry Toolkit
  • Market Intelligence Library
Market Intelligence
  • For Suppliers
  • For Buyers, Investors & Primes
Products
  • Events and Webinars
  • Articles & News
Events
MEDICAGO logo

MEDICAGO

1020 RTE DE L'EGLISE BUREAU 600, Québec G1V 3V9, Canada
DUNS #:
256743006
CAGE Code:
L8734
Type:
Manufacturer
Employees:
200-500
Annual Revenue:
$5M-$50M
Year Founded:
1999
Country of Origin:
Canada
Sectors Served:
US Federal
Company Security Level:
Unknown
Credit Card Usage:
No

Specialties and Expertise:

Contact/Location Info6

Size and minority status

Size
Small business
Ownership
African American
Alaska Native
Asian-Indian
Asian-Pacific
Hispanic
Minority-Unspecified
Native American
Native Hawaiian
Tribal
Unspecified
Veteran
Woman
Government Set-Aside Programs
AbilityOne
HUBZone
SBA 8(a)
SDVOSB
Small Disadvantaged Business (SDB)
Woman Owned Small Business (WOSB)

Commodity Codes3

PRODUCTS AND SERVICES1

Proficia Technology
2 past experiences
Medicago's plant-based Proficia technology uses transient protein expression in plant leaves for producing virus-like particles (VLPs) and therapeutic proteins.

Past experience2

other
Anti-Ebola Virus Monoclonal Antibodies (mAbs)
Medicago has received a task order from the Biomedical Advanced Research and Development Authority (BARDA) at the U.S. Department of...
other
Development of Antibodies Against SARS-CoV-2
Medicago’s platform can produce both vaccine and antibody candidates against COVID-19 disease. Medicago is using its technology plat...

External Recognition1

Best New Vaccine Technology/Platform
Medicago Awarded "Best New Vaccine Technology/Platform" for its plant-based Proficia technology a...
April, 25 2019

Known Locations Served6

My Notes
Contact
My Notes